Clinical trial
Skin Structure Infections With Suspected or Proven Methicillin-Resistant…
NCT00087490 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00087490 |
|---|---|
| Title | Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) |
| Official title | Linezolid in the Treatment of Subjects With Complicated Skin and Soft Tissue Infections Proven to be Due to Methicillin-Resistant Staphylococcus Aureus |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Skin/Soft Tissue Infections, Methicillin Resistant Staphylococcus Aureus (MRSA) |
| Intervention type | Drug |
| Interventions | linezolid, vancomycin |
| Enrollment | 1,077 |
| Start date | Oct 1, 2004 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jul 13, 2004 |
| Last update posted | Aug 8, 2012 |
| Countries | Argentina, Belgium, Brazil, Chile, Colombia, Italy, Malaysia, Mexico, Portugal, Russia, Singapore, South Africa and 4 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: